Use of dried blood spots in drug development: pharmacokinetic considerations.
Dried blood spots are increasingly being used in drug development. This commentary considers the pharmacokinetic issues that arise and compares these with those attached to plasma, the mainstay matrix. A common implicit use of these matrices is as a surrogate for plasma water, and to this extent, the critical assumption made is constancy in fraction unbound for plasma and, additionally for blood, constancy of hematocrit and blood cell affinity of compound. Often, these assumptions are reasonable and either matrix suffices, but not always. Then the value of one over the other matrix depends on the magnitude of the blood-to-plasma concentration ratio of drug, its clearance, and the cause of the deviation from constancy. Additional considerations are the kinetics of distribution within blood and those arising when the objective is assessment or comparison of bioavailability. Most of these issues can be explored and addressed in vitro prior to the main drug development program.
Rowland
Malcolm
M
Centre for Applied Pharmacokinetic Research, School of Pharmacy & Pharmaceutical Sciences, Stopford Building, University of Manchester, Manchester M139PT, UK. MRow190539@aol.com
Emmons
Gary T
GT
D001769:Blood; D015195:Drug Design; D006801:Humans; D010599:Pharmacokinetics
J Pharm Biomed Anal. 2007 Jul 27;44(3):658-64
17184953
J Clin Lab Anal. 1991;5(1):74-7
1999766
Clin Chim Acta. 2006 Nov;373(1-2):27-31
16797519
J Pharmacokinet Biopharm. 1977 Aug;5(4):359-75
894487
J Pharm Sci. 1972 Jan;61(1):70-4
5019220
Anal Bioanal Chem. 2009 Jun;394(4):1171-82
19387621
Pharm Res. 1988 Feb;5(2):80-5
3073383
Anal Chem. 2009 Feb 15;81(4):1557-63
19154107
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Mar 15;877(8-9):799-806
19237324
Ther Drug Monit. 2009 Jun;31(3):327-36
19349929
J Pharm Sci. 1993 Mar;82(3):340-1
7680714
J Pharm Biomed Anal. 2009 Nov 1;50(4):664-70
19155152
J Pharm Sci. 2005 Jun;94(6):1259-76
15858854
Biomed Chromatogr. 2010 Jan;24(1):49-65
20017122
J Pharmacokinet Biopharm. 1994 Oct;22(5):327-65
7791036
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jul 1;870(1):32-7
18550454
J Pharm Biomed Anal. 2009 Feb 20;49(2):393-400
19059744
Pediatrics. 1963 Sep;32:338-43
14063511
Pharm Res. 2007 May;24(5):918-33
17372687
Demography. 2007 Nov;44(4):899-925
18232218
J Pharm Biomed Anal. 2009 May 1;49(4):1034-9
19269771
J Pharmacol Exp Ther. 1998 Nov;287(2):457-68
9808668
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Sep 25;809(1):153-8
15282106
J Nutr. 2001 May;131(5):1631S-6S
11340130
Clin Biochem. 2005 Jun;38(6):552-7
15885236